Encompass Health (EHC) Receiving Positive Press Coverage, Accern Reports

Media coverage about Encompass Health (NYSE:EHC) has trended positive recently, according to Accern. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Encompass Health earned a coverage optimism score of 0.49 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.4690862921607 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

NYSE:EHC opened at $79.52 on Friday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 1.73. The company has a market cap of $7.81 billion, a PE ratio of 28.81, a PEG ratio of 1.72 and a beta of 0.32. Encompass Health has a 1-year low of $43.27 and a 1-year high of $80.13.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Stockholders of record on Monday, October 1st will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 1.36%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Friday, September 28th. Encompass Health’s payout ratio is 36.23%.

Several research firms have recently weighed in on EHC. Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a report on Thursday, July 26th. Credit Suisse Group lifted their target price on shares of Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a report on Thursday, July 26th. Mizuho reaffirmed a “buy” rating and set a $82.00 target price on shares of Encompass Health in a report on Thursday, July 26th. ValuEngine raised shares of Encompass Health from a “buy” rating to a “strong-buy” rating in a report on Friday, April 27th. Finally, Royal Bank of Canada lifted their target price on shares of Encompass Health to $69.00 and gave the company an “outperform” rating in a report on Monday, April 30th. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $73.00.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also: How Do I Invest in Dividend Stocks

Insider Buying and Selling by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply